Search Results - "Kirshner, J."
-
1
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline Update
Published in Journal of clinical oncology (10-08-2022)“…To provide updated evidence- and consensus-based guideline recommendations to practicing oncologists and others on the management of brain metastases for…”
Get full text
Journal Article -
2
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
Published in Annals of surgical oncology (01-01-2017)“…Purpose A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a…”
Get full text
Journal Article -
3
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
Published in Practical Radiation Oncology (01-11-2016)“…A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a focused…”
Get full text
Journal Article -
4
Multicenter Phase II Trial of Weekly Paclitaxel in Women With Metastatic Breast Cancer
Published in Journal of clinical oncology (15-11-2001)“…We evaluated the safety and efficacy of weekly paclitaxel therapy in women with metastatic breast cancer in a phase II multicenter trial. Entry criteria were…”
Get full text
Journal Article -
5
Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology
Published in Journal of clinical oncology (01-03-2001)“…To determine indications for the use of postmastectomy radiotherapy (PMRT) for patients with invasive breast cancer with involved axillary lymph nodes or…”
Get full text
Journal Article -
6
Prevention of Pegfilgrastim-Induced Bone Pain: A Phase III Double-Blind Placebo-Controlled Randomized Clinical Trial of the University of Rochester Cancer Center Clinical Community Oncology Program Research Base
Published in Journal of clinical oncology (01-06-2012)“…Pegfilgrastim-induced bone pain is a significant clinical problem that may result in discontinuation of pegfilgrastim and lead to less effective chemotherapy…”
Get full text
Journal Article -
7
NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim
Published in Supportive care in cancer (01-04-2018)“…Purpose Mild-to-moderate bone pain is a commonly reported adverse event (AE) associated with pegfilgrastim. We evaluated the effect of prophylactic naproxen or…”
Get full text
Journal Article -
8
Differential Effects of Paroxetine on Fatigue and Depression: A Randomized, Double-Blind Trial From the University of Rochester Cancer Center Community Clinical Oncology Program
Published in Journal of clinical oncology (15-12-2003)“…Fatigue and depression typically occur together in cancer patients, suggesting a common etiology, perhaps based on serotonin. This randomized clinical trial…”
Get full text
Journal Article -
9
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
Published in European journal of cancer (1990) (01-03-2011)“…Abstract Background Chemotherapy-induced ovarian failure (CIOF) is a frequent side-effect of adjuvant chemotherapy that results in rapid bone loss. We…”
Get full text
Journal Article -
10
Prevalence of complementary and alternative medicine use in cancer patients during treatment
Published in Supportive care in cancer (01-10-2005)“…To assess complementary and alternative medicine (CAM) therapies being utilized by cancer patients during treatment and communication about CAM usage between…”
Get full text
Journal Article -
11
Oral clonidine in postmenopausal Patients with breast Cancer experiencing tamoxifen-induced Hot flashes : A University of Rochester Cancer Center community Clinical Oncology program study
Published in Annals of internal medicine (16-05-2000)“…Hot flashes are the most frequently reported side effect of tamoxifen treatment. Although hormones are an effective treatment, their safety is questionable in…”
Get full text
Journal Article -
12
-
13
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update
Published in Journal of clinical oncology (10-09-2018)“…Purpose To update evidence-based guideline recommendations for practicing oncologists and others on systemic therapy for patients with human epidermal growth…”
Get full text
Journal Article -
14
Phase I Clinical Study of Fish Oil Fatty Acid Capsules for Patients with Cancer Cachexia: Cancer and Leukemia Group B Study 9473
Published in Clinical cancer research (01-12-1999)“…The purpose of this study was to determine the maximum tolerated dose and dose-limiting toxicities of fish oil fatty acid capsules containing Ï-3 fatty acid…”
Get full text
Journal Article -
15
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline Update
Published in Journal of clinical oncology (10-08-2022)“…To update evidence-based guideline recommendations to practicing oncologists and others on systemic therapy for patients with human epidermal growth factor…”
Get full text
Journal Article -
16
DNA Binding by Kaposi's Sarcoma-Associated Herpesvirus Lytic Switch Protein Is Necessary for Transcriptional Activation of Two Viral Delayed Early Promoters
Published in Journal of Virology (01-08-2001)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
17
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Published in Journal of clinical oncology (01-07-2014)“…To provide evidence-based recommendations to practicing oncologists and others on systemic therapy for patients with human epidermal growth factor receptor 2…”
Get full text
Journal Article -
18
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update
Published in Journal of clinical oncology (20-09-2018)“…Purpose To update the formal expert consensus-based guideline recommendations for practicing oncologists and others on the management of brain metastases for…”
Get full text
Journal Article -
19
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update
Published in Journal of clinical oncology (20-12-2016)“…Purpose A joint American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology panel convened to develop a…”
Get full text
Journal Article -
20
Effect of a Nausea Expectancy Manipulation on Chemotherapy-Induced Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study
Published in Journal of pain and symptom management (01-04-2008)“…Abstract Several studies have shown that patients' expectancies for the development of nausea following chemotherapy are robust predictors of that…”
Get full text
Journal Article